Jefferies Group LLC Iovance Biotherapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Sep 21, 2023	SELL	$6.38 - $18.33 $1.29 Million - $3.7 Million	-201,600 Reduced 84.18%	37,900 $418,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $241,802 - $694,706	37,900 New	37,900 $418,000
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $2.97 Million - $4.57 Million	-239,500 Closed	0 $0
Q4 2021 Sep 21, 2023	SELL	$16.55 - $27.63 $1 Million - $1.67 Million	-60,500 Reduced 20.17%	239,500 $4.57 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $3.96 Million - $6.62 Million	239,500 New	239,500 $4.57 Million
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $6.11 Million - $7.99 Million	-300,000 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$16.33 - $33.07 $1.47 Million - $2.97 Million	89,900 Added 42.79%	300,000 $7.81 Million
Q2 2021 Aug 20, 2021	SELL	$16.33 - $33.07 $485 Million - $982 Million	-29,700,000 Reduced 99.0%	300,000 $7.81 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $486 Million - $985 Million	29,789,900 Added 14178.91%	30,000,000 $7.81 Million
Q1 2021 Sep 21, 2023	SELL	$28.67 - $52.59 $11.1 Million - $20.4 Million	-387,100 Reduced 64.82%	210,100 $6.65 Million
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $11.1 Million - $20.4 Million	-387,100 Reduced 64.82%	210,100 $6.65 Million
Q4 2020 Sep 21, 2023	BUY	$28.04 - $50.26 $16.7 Million - $30 Million	597,200 New	597,200 $27.7 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $16.7 Million - $30 Million	597,200 New	597,200 $27.7 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $693,750 - $907,499	-25,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $12.1 Million - $18.2 Million	-442,900 Reduced 94.66%	25,000 $686,000
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $7.97 Million - $15.8 Million	407,900 Added 679.83%	467,900 $14 Million
Q4 2019 Feb 13, 2020	SELL	$17.95 - $29.41 $954,940 - $1.56 Million	-53,200 Reduced 47.0%	60,000 $1.66 Million
Q3 2019 Nov 13, 2019	BUY	$17.99 - $26.0 $1.14 Million - $1.64 Million	63,200 Added 126.4%	113,200 $2.06 Million
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $488,999 - $1.23 Million	50,000 New	50,000 $1.23 Million
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $224,100 - $305,100	-18,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $145,800 - $351,000	18,000 New	18,000 $304,000

Others Institutions Holding IOVA

# of Institutions

316

Shares Held

244M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $898M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account